Amsterdam, Netherlands : 1 - 3 February 2018
The target audience for this meeting is basic, translational and clinical scientists, as well as physicians engaged in the challenges of personalised medicine, the development of new therapeutics and clinical implementation.
To ensure the best interaction with delegates, exhibitors will be invited to take part in all networking sessions available at the conference. Visit our dedicated page about Networking for more information.
|Cell Signaling Technology|
|Don Whitley Scientific|
The exhibition will occur within the Lecture Hall and all exhibitors will have access to the scientific sessions. Have a virtual tour of the venue (a converted former church) which allows us to accommodate an exhibition of 6 stands:
If you are visiting this site as a potential sponsor or exhibitor please contact:
Business Development and Marketing Officer
+44 (0)11574 84513
Dietary requirements (in-person events only)
Please indicate any special dietary requirements here. We will try to cater to all dietary requirements and we will write to you if there is any problem.
Sharing your details with others
Please click below if you agree we can share your name, email and postal address with participants and exhibitors, who may use them to contact you.
Please note: you have selected NOT to share your details with participants and exhibitors.
You can click above to change this.
We will use the email address in your EACR account to communicate with you. However, during the checkout process you will need to enter the name and contact details of the person paying for your registration, if this is different to your own details. Please make sure you have this information to hand.
Terms and Conditions
Please read our Membership and Events Terms and Conditions before completing your registration.
Photography and video
Please note that we will be taking photographs and video at the conference for publicity and marketing purposes. If you do not wish to take part please inform the photographer.
The EACR is grateful for the continued support of its Industry Partners: